Dole plc DOLE Holds Steady Near MidRange Amid Modest Dip Netflixs The Four Seasons Season 2 Draws Positive Critical Response Potentially Lifting Platform Engagement Exagen Inc XGN Q1 2026 Earnings EPS Beats Estimates by 1515 Revenue Details Withheld Stock Declines ImmunityBio Gains Momentum as FDA Accepts ANKTIVA sBLA for Bladder Cancer Expansion